Studies on the molecular mechanism of the drug metabolism in prostate cancer, pc3 cell lines

Download
2014
Dilek Kançağı, Derya
Metabolic changes observed in prostate cancer are very important for both the course of the event and therapeutic way to be decided. One of the effective chemotherapeutic agent showing antitumour activity against prostate cancer is Docetaxel. The metabolism of this drug is important in term of its effectiveness. In this study we determine the effect of CYP1A1, CYP3A4 and GSTP1 enzyme inhibitors on the efficacy of the docetaxel. For this purpose, the gene expressions and activities of these enzymes were analyzed in PC3 (androgen-independent PC cell lines) and PNT1A (immortalized prostatic cell lines) cells by using real-time PCR and activity assays. Alpha-naphthoflavone, ketaconozole and quercetin were used as the inhibitors of CYP1A1, CYP3A4 and GSTP, respectively. In order to investigate the potential of these inhibitors in docetaxel metabolism, PC3 and PNT1A cells were treated with inhibitors in combination with docetaxel and the cell viability and cell death (apoptosis/necrosis) was analyzed by using WST-1 and Annexin V assays, respectively. According to our results, the concentration which gives 70% and 60% cell viability after 24 and 48 hours applications were found as 4 µM for docetaxel, 1000 nM for alpha-naphthoflavone, 56.5 µM for ketoconazole and 300 µM for quercetin. IC50 values were calculated as 15.1 µM for alpha-naphthoflavone, 118.7 µM for ketoconazole and 692 µM for quercetin from the activity assays. Docetaxel application alone and in combination with the inhibitors showed differences in both mRNA levels and cell viability status in treated/untreated PC3 and PNT1A cells at predetermined concentrations. In conclusion, our results showed that, the application of docetaxel with enzyme specific inhibitors is more effective by increasing the effects of docetaxel in PC3 cells. Further studies about the metabolism of drugs will help for the development of a therapy that would increase the efficacy of the drugs which might provide a better chance for the patience survival.

Suggestions

DETERMINATION OF THE RELATIONSHIP BETWEEN DOXORUBICIN RESISTANCE AND WNT SIGNALING PATHWAY IN HELA AND K562 CELL LINES
Mutlu, Pelin; Pourianazar, Negar Taghavi; Yucel, Meral; Gündüz, Ufuk (2018-01-01)
Activation of the Wnt signaling in some types of cancer and its relation with chemotherapy resistance is a very interesting issue that has been emphasized in recent years. Although, it is known that increase in the activity of beta-catenin is important in blast transformation and drug resistance, the underlying mechanisms are still unclear. In this study, changes in the expression levels of 186 genes that are thought to be important in drug resistance and Wnt signaling pathways were determined by using qPCR...
Relationship between the nat genetic polymorphism and susceptibility to prostate cancer
Dilek, Derya; Güray, Tülin; Department of Biology (2008)
Prostate cancer (PCa) is one of the most prevelant cancers in males in many countries, increasing in frequency with age. PCa incidence and mortality rates are not evenly distributed worldwide. Family history is an established risk factor for prostate cancer and families demonstrating autosomal dominant or X-linked transmission of susceptibility have been observed. Although an increasing number of candidate genes or hereditary prostate cancer susceptibility have been identified, only 5 to 10 percent of prost...
Comparison of methods for prediction of prostate cancer in Turkish men with PSA levels of 0-10 ng/mL
GÜLKESEN, KEMAL HAKAN; KÖKSAL, İSMAİL TÜRKER; BİLGE, UĞUR; Saka, O. (2010-07-01)
Purpose: Several concepts to improve the diagnostic accuracy of prostate specific antigen (PSA) for prediction of prostate cancer have been studied. The aim of this study was to examine and compare the methods used for improving the diagnostic accuracy of PSA in a country with low incidence of prostate cancer
Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer
BEGIK, Oguzhan; ÖYKEN, MERVE; ALICAN, Tuna Cinkilli; Can, Tolga; Erson Bensan, Ayşe Elif (2017-07-01)
Certain aspects of diagnosis, prognosis, and treatment of cancer patients are still important challenges to be addressed. Therefore, we propose a pipeline to uncover patterns of alternative polyadenylation (APA), a hidden complexity in cancer transcriptomes, to further accelerate efforts to discover novel cancer genes and pathways. Here, we analyzed expression data for 1045 cancer patients and found a significant shift in usage of poly(A) signals in common tumor types (breast, colon, lung, prostate, gastric...
DEVELOPMENT OF A HYDROGEL BASED PROSTATE TUMOR MODEL FOR CANCER CELL MIGRATION STUDIES
Demirkaya, Damla; Gözen, Ayşe Gül; Antmen Altunsoy, Ezgi; Department of Molecular Biology and Genetics (2022-1-12)
Prostate cancer is the second most diagnosed cancer in men and relapse due to the metastasis of cancer cells is the main reason of the high number of deaths in prostate cancer patients. Thus, there is a growing need for a tumor model to study the prostate cancer metastasis. In this study, a 3D model consisting of two natural polymer hydrogels (methacrylated collagen and methacrylated hyaluronic acid) with tunable mechanical and chemical properties carrying spheroids of two different prostate cancer cell lin...
Citation Formats
D. Dilek Kançağı, “Studies on the molecular mechanism of the drug metabolism in prostate cancer, pc3 cell lines,” Ph.D. - Doctoral Program, Middle East Technical University, 2014.